PofoliaShared via Pofolia

EP Europace· 2016Q1· Guideline

2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS

Paulus Kirchhof, Stefano Benussi, Dipak Kotecha, Anders Ahlsson et al.

Short summary

The 2016 ESC Guidelines for atrial fibrillation management, developed with EACTS, offer recommendations for healthcare professionals to guide clinical judgment and treatment strategies.

AI-generated from the title and abstract; the full text is not read.

Key points

  • The 2016 ESC Guidelines provide a framework for managing atrial fibrillation, based on scientific evidence available in 2016.
  • Healthcare professionals are encouraged to use these guidelines to inform clinical judgment and patient care strategies.
  • The guidelines highlight the responsibility of health professionals to consider individual patient conditions and consult with patients and caregivers.
  • These guidelines do not override the need to adhere to official recommendations from public health authorities or professional ethical obligations.

AI-generated from the title and abstract; the full text is not read.

Abstract

The ESC Guidelines represent the views of the ESC and were produced after careful consideration of the scientific and medical knowledge and the evidence available at the time of their publication. The ESC is not responsible in the event of any contradiction, discrepancy and/or ambiguity between the ESC Guidelines and any other official recommendations or guidelines issued by the relevant public health authorities, in particular in relation to good use of healthcare or therapeutic strategies. Health professionals are encouraged to take the ESC Guidelines fully into account when exercising their clinical judgment, as well as in the determination and the implementation of preventive, diagnostic or therapeutic medical strategies; however, the ESC Guidelines do not override, in any way whatsoever, the individual responsibility of health professionals to make appropriate and accurate decisions in consideration of each patient's health condition and in consultation with that patient and, where appropriate and/or necessary, the patient's caregiver. Nor do the ESC Guidelines exempt health professionals from taking into full and careful consideration the relevant official updated recommendations or guidelines issued by the competent public health authorities, in order to manage each patient's case in light of the scientifically accepted data pursuant to their respective ethical and professional obligations. It is also the health professional's responsibility to verify the applicable rules and regulations relating to drugs and medical devices at the time of prescription.

The authors' abstract, as published at the source. EP Europace, 2016 · DOI ↗

TakeawaysPremium
Ask the paperFree account

Continue with a free account

Ask the paper: 3 free questions a day about this paper; save it, get its citation, new summaries every day for your field. Takeaways are Premium.

Continue free on the web

Sign in with Google or Apple; no card needed. You come back to this paper.

On your phone:

Field: Cardiology and Cardiovascular Medicine

Cardiology and Cardiovascular MedicineMedicine